Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bello

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Human Antibodies|April 26, 2020
Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto NigeriaO Erhabor, S Y Mohammad, L Bello, et al.
Leukemia|October 1, 1996
Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemiaC Richard, I Romón, M Perez-Encinas, et al.
European Journal of Medicinal Chemistry|November 15, 2017
1,4-Naphthoquinones potently inhibiting P2X7 receptor activityR X Faria, F H Oliveira, J P Salles, et al.
European Journal of Neurology|May 5, 2016
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotypeC Bertolin, G Querin, E Da Re, et al.
Medical Mycology|June 21, 2012
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)I Jarque, M Tormo, J L Bello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxaneHarold J Burstein, Anthony D Elias, Hope S Rugo, et al.
Annals of Hematology|March 31, 2016
Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trialE González-Barca, M Canales, A Salar, et al.
European Journal of Neurology|August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task ForceR Soffietti, B G Baumert, L Bello, et al.
Bioorganic & Medicinal Chemistry|December 12, 2018
8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine MacrophagesP A F Pacheco, R M S Galvão, A F M Faria, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 15, 2021
Physalin pool from Physalis angulata L. leaves and physalin D inhibit P2X7 receptor function in vitro and acute lung injury in vivoJ C C Arruda, N C Rocha, E G Santos, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Human Antibodies|April 26, 2020
Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto NigeriaO Erhabor, S Y Mohammad, L Bello, et al.
Leukemia|October 1, 1996
Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemiaC Richard, I Romón, M Perez-Encinas, et al.
European Journal of Medicinal Chemistry|November 15, 2017
1,4-Naphthoquinones potently inhibiting P2X7 receptor activityR X Faria, F H Oliveira, J P Salles, et al.
European Journal of Neurology|May 5, 2016
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotypeC Bertolin, G Querin, E Da Re, et al.
Medical Mycology|June 21, 2012
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)I Jarque, M Tormo, J L Bello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxaneHarold J Burstein, Anthony D Elias, Hope S Rugo, et al.
Annals of Hematology|March 31, 2016
Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trialE González-Barca, M Canales, A Salar, et al.
European Journal of Neurology|August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task ForceR Soffietti, B G Baumert, L Bello, et al.
Bioorganic & Medicinal Chemistry|December 12, 2018
8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine MacrophagesP A F Pacheco, R M S Galvão, A F M Faria, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 15, 2021
Physalin pool from Physalis angulata L. leaves and physalin D inhibit P2X7 receptor function in vitro and acute lung injury in vivoJ C C Arruda, N C Rocha, E G Santos, et al.
Pageof 18